Biomarkers to predict advanced liver diseases

QR Code

Biomarkers to predict advanced liver diseases

Background: Chronic liver disease (CLD) is one of the leading causes of morbidity and mortality, accounting for more than two million deaths annually worldwide. In recent years, Non-alcoholic Fatty Liver Disease (NAFLD) has been a fast-emerging cause of CLD, which can progress to advanced conditions...

Full description

Bibliographic Details
Main Author:	Alenezi, Yusef
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2024
Subjects:	Liver disease; Biomarkers; Disease progression
Online Access:	https://eprints.nottingham.ac.uk/78712/

Similar Items

Biomarkers of drug-induced liver injury
by: Atallah, Edmond
Published: (2024)

Biomarkers of progressive lung fibrosis
by: Khan, Fasihul
Published: (2022)

The identification of chronic liver disease in primary care using non-invasive diagnostics within a novel pathway
by: Harman, David J.
Published: (2017)

Risk stratification of chronic liver disease in the community
by: Harris, Rebecca
Published: (2019)

The role of intramyocellular lipid content in the physiological changes observed in inactivity, exercise, and non-alcoholic fatty liver disease
by: Chivaka, Prince
Published: (2023)

Herbal and dietary supplement use in Thai patients with chronic kidney disease (CKD) and their association with progression of CKD
by: Tangkiatkumjai, Mayuree
Published: (2014)

Investigating serum biomarkers, disease pathways and vitamin D in association with cardiovascular disease in great apes
by: Jarvis, Rachel
Published: (2025)

Modelling non-alcoholic fatty liver disease (NAFLD) using human induced pluripotent stem cell (hiPSC)-derived hepatocytes
by: Lo, Peggy Cho Kiu
Published: (2022)

Elucidating feline hepatic lipidosis through serum biochemistry, histopathology and gene expression in the Klang valley stray cats
by: Salleh, Muhammad Fadzly
Published: (2020)

Practical detection of a definitive biomarker panel for Alzheimer's disease: comparisons between matched plasma and cerebrospinal fluid
by: Richens, Joanna L., et al.
Published: (2014)

Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review
by: Harris, Rebecca, et al.
Published: (2017)

Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using Transient Elastography
by: Harman, David J., et al.
Published: (2018)

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
by: Maher, Toby M., et al.
Published: (2017)

Seroepidemiology of Toxoplasma gondii infection in patients with liver disease in eastern China
by: Tian, A.L., et al.
Published: (2017)

ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
by: Daniels, Samuel J., et al.
Published: (2018)

Cloning, Expression and Characterization of Hepatitis B Large Surface Antigen In Yeast System
by: Mohamad Sinang, Fazia
Published: (2010)

The role of ethnicity in the increased susceptibility to non-alcoholic fatty liver disease in people of Indian origin
by: Chalmers, Jane
Published: (2021)

Low serum 25-hydroxyvitamin D concentrations are associated with non-alcoholic fatty liver disease in adolescents independent of adiposity
by: Black, Lucinda, et al.
Published: (2014)

THE IDENTIFICATION OF BIOMARKERS TO PREDICT RESPONSE TO TREATMENTS IN ASTHMA
by: Lissa, Sutherland
Published: (2019)

Assessment of dietary factors in patients with nonalcoholic fatty liver disease and an intervention study to investigate the effects of low glycaemic index diet
by: Al-Awadi, Amina
Published: (2023)

Haemodynamic evaluation of coronary artery plaques : prediction of coronary atherosclerosis and disease progression
by: Chaichana, Thanapong
Published: (2012)

Cholesteryl ester transfer protein gene ploymorphisms increase the risk of fatty liver in females independent of adisposity
by: Adams, L., et al.
Published: (2012)

Molecular approaches to the diagnosis and monitoring of production diseases in pigs
by: Giles, Timothy A., et al.
Published: (2017)

Exploring the experience of people at-risk of Non-alcoholic Fatty Liver Disease in making and maintaining lifestyle changes
by: Mehta, Rhian Mehta
Published: (2024)

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study
by: Morling, Joanne R., et al.
Published: (2014)

Mechanism-based intervention in Non-Alcoholic Fatty Liver Disease: mapping the muscle-liver axis and exploring the effect of L-carnitine on liver fat, insulin sensitivity and mitochondrial energy kinetics
by: Thiagarajan, Prarthana
Published: (2021)

Isoaspartate, Carbamoyl phosphate synthase-1, and carbonic anhydrase-III as biomarkers of liver injury
by: Carter, Wayne, et al.
Published: (2016)

The effect of circulatory dysfunction upon the liver in haemodialysis patients
by: Grant, Claire
Published: (2019)

The histomorphological analysis of liver following administration of low doses of diclofenac and ibuprofen
by: Mohanambal, Moorthy, et al.
Published: (2009)

Proteomic and transcriptomic analyses of protein biomarkers during early hyperinfection in strongyloidiasis
by: Al-Zihiry, Khalid Jameel Kadhim
Published: (2016)

Review on Cardiovascular Risk Prediction
by: Ruwanpathirana, T., et al.
Published: (2015)

Exploring the role of cell signalling and DNA damage pathways in primary surgically resected ovarian cancer
by: Alabdullah, Mussalam Layth
Published: (2021)

Hepatoprotective activity of Dicranopteris linearis (Burm. f.) Underw. leaf methanol extract and its ethyl acetate fraction
by: Kamisan, Farah Hidayah
Published: (2017)

A study on biomarkers in workers exposure to benzene
by: Cao, J., et al.
Published: (2002)

What is the risk of progressive multifocal leukoencephalopathy in patients with ulcerative colitis or Crohn’s Disease treated with vedolizumab?
by: Card, Timothy R., et al.
Published: (2018)

Rationalising the role of Keratin 9 as a biomarker for Alzheimer’s disease
by: Richens, Joanna L., et al.
Published: (2016)

Hip fracture risk in patients with alcoholic cirrhosis: a population-based study using English and Danish data
by: Otete, Harmony E., et al.
Published: (2018)

Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
by: Maeda, H., et al.
Published: (2015)

Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection
by: He, Jun-Jun, et al.
Published: (2016)

A potential biomarker for the Permian-Triassic ecological crisis
by: Grice, Kliti, et al.
Published: (2005)